Aldeyra Therapeutics CEO Todd Brady's 2022 pay slips 17% to $2.9M
Aldeyra Therapeutics reports 2022 executive compensation
By ExecPay News
Published: May 23, 2023
Aldeyra Therapeutics reported fiscal year 2022 executive compensation information on May 23, 2023.
In 2022, three executives at Aldeyra Therapeutics received on average a compensation package of $2.3M, a 3% increase compared to previous year.
Average pay of disclosed executives at Aldeyra Therapeutics
Todd C. Brady, Chief Executive Officer, received $2.9M in total, which decreased by 17% compared to 2021. 40% of Brady's compensation, or $1.1M, was in stock awards. Brady also received $338K in non-equity incentive plan, $819K in option awards, $559K in salary, as well as $12K in other compensation.
Stephen G. Machatha, Chief Development Officer, received a compensation package of $2.6M, which increased by 79% compared to previous year. 45% of the compensation package, or $1.2M, was in stock awards.
Bruce Greenberg, Chief Financial Officer, earned $1.5M in 2022.
Related executives
You may also like
Source: SEC filing on May 23, 2023.